BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naeem M, Dahiya M, Clark JI, Creech SD, Alkan S. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis. Hum Pathol 2002;33:1182-7. [PMID: 12514786 DOI: 10.1053/hupa.2002.129199] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Krug LM, Crapanzano JP, Azzoli CG, Miller VA, Rizvi N, Gomez J, Kris MG, Pizzo B, Tyson L, Dunne M, Heelan RT. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial. Cancer 2005;103:2128-31. [PMID: 15812822 DOI: 10.1002/cncr.21000] [Cited by in Crossref: 119] [Cited by in F6Publishing: 99] [Article Influence: 7.0] [Reference Citation Analysis]
2 Choong NW, Ma PC, Salgia R. Therapeutic targeting of receptor tyrosine kinases in lung cancer. Expert Opinion on Therapeutic Targets 2005;9:533-59. [DOI: 10.1517/14728222.9.3.533] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mori D, Akashi M, Baba K, Morito K, Shibaki M, Hashimoto M, Nakamura A, Mawatari S, Sato S. Gastric undifferentiated carcinoma with diffuse c-kit overexpression and focal neuroendocrine differentiation. Pathol Res Pract. 2013;209:132-134. [PMID: 23347914 DOI: 10.1016/j.prp.2012.12.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Spigel DR, Hainsworth JD, Simons L, Meng C, Burris HA, Yardley DA, Grapski R, Schreeder M, Mallidi PV, Greco FA. Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network. Journal of Thoracic Oncology 2007;2:854-61. [DOI: 10.1097/jto.0b013e31814617b7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
5 Madhusudan S, Ganesan TS. Tyrosine kinase inhibitors and cancer therapy. Recent Results Cancer Res 2007;172:25-44. [PMID: 17607934 DOI: 10.1007/978-3-540-31209-3_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Terada T. Primary esophageal small cell carcinoma with brain metastasis and with CD56, KIT, and PDGFRA expressions. Pathol Oncol Res. 2012;18:1091-1093. [PMID: 21626441 DOI: 10.1007/s12253-011-9374-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Kurt E, Sezgin C, Evrensel T, Yalcinkaya U, Kanat O, Veral A, Demiray M, Arslan M, Karabulut B, Ercan I. Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma. Int J Clin Pract. 2005;59:537-543. [PMID: 15857349 DOI: 10.1111/j.1368-5031.2005.00447.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Terada T. Esophageal small cell carcinoma without neuroendocrine features but with KIT and PDGFRA expression: KIT as a useful marker of this type of tumor. J Gastrointest Cancer 2014;45 Suppl 1:132-5. [PMID: 24604264 DOI: 10.1007/s12029-014-9595-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Sheu LF, Lee WC, Lee HS, Kao WY, Chen A. Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium. J Pathol 2005;207:216-23. [PMID: 16021677 DOI: 10.1002/path.1822] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
10 Luo L, Zeng J, Liang B, Zhao Z, Sun L, Cao D, Yang J, Shen K. Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome. Exp Mol Pathol 2011;91:596-602. [PMID: 21787767 DOI: 10.1016/j.yexmp.2011.06.005] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
11 Yokouchi H, Nishihara H, Harada T, Ishida T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Higuchi M, Honjo O, Minami Y, Watanabe N, Goto A, Suzuki H, Dosaka-Akita H, Isobe H, Nishimura M, Munakata M. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker. Oncotarget 2017;8:39711-26. [PMID: 28055980 DOI: 10.18632/oncotarget.14410] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Camps C, Sirera R, Bremnes RM, Garde J, Safont MJ, Blasco A, Berrocal A, Sánchez JJ, Calabuig C, Martorell M. Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications. Lung Cancer 2006;52:343-7. [PMID: 16574270 DOI: 10.1016/j.lungcan.2006.02.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
13 Terada T, Maruo H. Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. World J Gastroenterol 2012; 18(13): 1545-1551 [PMID: 22509088 DOI: 10.3748/wjg.v18.i13.1545] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
14 Tang Y, Liang X, Zheng M, Zhu Z, Zhu G, Yang J, Chen Y. Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol 2010;46:311-6. [PMID: 20219417 DOI: 10.1016/j.oraloncology.2010.02.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
15 Terada T. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations. Pathol Int 2009;59:247-50. [PMID: 19351368 DOI: 10.1111/j.1440-1827.2009.02358.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
16 Rohr U, Rehfeld N, Pflugfelder L, Geddert H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele K, Gabbert HE, Germing U, Kronenwett R, Haas R. Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer: Prognostic Impact of c-kit in SCLC. Int J Cancer 2004;111:259-63. [DOI: 10.1002/ijc.20252] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
17 Madhusudan S, Ganesan TS. Tyrosine kinase inhibitors in cancer therapy. Clin Biochem 2004;37:618-35. [PMID: 15234243 DOI: 10.1016/j.clinbiochem.2004.05.006] [Cited by in Crossref: 132] [Cited by in F6Publishing: 117] [Article Influence: 7.8] [Reference Citation Analysis]
18 Giordano G, Campanini N, Rocco A, Donofrio V, Bertolini P, Falleti J, Pettinato G. C-kit protein expression in Wilms' tumour: an immunohistochemical study. Eur J Surg Oncol 2009;35:629-35. [PMID: 19010635 DOI: 10.1016/j.ejso.2008.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Decaudin D, de Cremoux P, Sastre X, Judde JG, Nemati F, Tran-Perennou C, Fréneaux P, Livartowski A, Pouillart P, Poupon MF. In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy. Int J Cancer 2005;113:849-56. [PMID: 15499612 DOI: 10.1002/ijc.20652] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
20 Fischer B, Marinov M, Arcaro A. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far? Cancer Treat Rev 2007;33:391-406. [PMID: 17368733 DOI: 10.1016/j.ctrv.2007.01.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
21 Erler BS, Presby MM, Finch M, Hodges A, Horowitz K, Topilow AA, Matulewicz T. CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma. Tumor Biol 2011;32:107-11. [DOI: 10.1007/s13277-010-0104-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
22 Sever M, Jones TD, Roth LM, Karim FWA, Zheng W, Michael H, Hattab EM, Emerson RE, Baldridge LA, Cheng L. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications. Mod Pathol 2005;18:1411-6. [DOI: 10.1038/modpathol.3800463] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
23 Swarts DR, Ramaekers FC, Speel EJ. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochim Biophys Acta 2012;1826:255-71. [PMID: 22579738 DOI: 10.1016/j.bbcan.2012.05.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
24 Aydin O, Yildiz L, Kefeli M, Kandemir B. CD117 expression in normal, neoplastic, inflammatory, and reactive lesions of the thyroid. Pathol Res Pract 2008;204:359-65. [PMID: 18337018 DOI: 10.1016/j.prp.2008.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
25 Jorcano S, Casado A, Berenguer J, Arenas M, Rovirosa A, Colomo L. Primary neuroendocrine small cell undifferentiated carcinoma of the parotid gland. Clin Transl Oncol 2008;10:303-6. [DOI: 10.1007/s12094-008-0203-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
26 Saint-Blancard P, Hervouet M, Chapuis O. [Poorly differentiated endocrine carcinoma of the colon]. Rev Med Interne. 2010;31:e10-e12. [PMID: 20167397 DOI: 10.1016/j.revmed.2009.03.368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Hong SM, Hwang I, Song DE, Choi J, Yu E. Clinical and prognostic significances of nuclear and cytoplasmic KIT expressions in extrahepatic bile duct carcinomas. Mod Pathol 2007;20:562-9. [PMID: 17396144 DOI: 10.1038/modpathol.3800771] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
28 Chung S, Sicklick JK, Ray P, Hall DA. Development of a Soluble KIT Electrochemical Aptasensor for Cancer Theranostics. ACS Sens 2021;6:1971-9. [PMID: 34008963 DOI: 10.1021/acssensors.1c00535] [Reference Citation Analysis]
29 Yasuda A, Sawai H, Takahashi H, Ochi N, Matsuo Y, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells. Mol Cancer. 2006;5:46. [PMID: 17044945 DOI: 10.1186/1476-4598-5-46] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 4.3] [Reference Citation Analysis]
30 Dow N, Giblen G, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol. 2006;23:111-119. [PMID: 17193824 DOI: 10.1053/j.semdp.2006.09.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
31 Pocrnich CE, Ramalingam P, Euscher ED, Malpica A. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases. Am J Surg Pathol. 2016;40:577-586. [PMID: 26945341 DOI: 10.1097/pas.0000000000000633] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 9.2] [Reference Citation Analysis]
32 Horn L, Castellanos EL, Johnson DH. Update on new drugs in small cell lung cancer. Expert Opin Investig Drugs 2011;20:441-5. [PMID: 21395484 DOI: 10.1517/13543784.2011.553185] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sakabe T, Azumi J, Haruki T, Umekita Y, Nakamura H, Shiota G. CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer. Oncol Lett 2017;13:3703-8. [PMID: 28521472 DOI: 10.3892/ol.2017.5925] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
34 Uccella S, La Rosa S, Volante M, Papotti M. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms. Endocr Pathol. 2018;29:150-168. [PMID: 29520563 DOI: 10.1007/s12022-018-9522-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 10.8] [Reference Citation Analysis]
35 Terada T. Primary small cell carcinoma of the mediastinum: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2009;26:247-50. [PMID: 18989797 DOI: 10.1007/s12032-008-9116-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
36 Terada T. Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2010;27:1119-22. [PMID: 19859843 DOI: 10.1007/s12032-009-9345-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
37 López-Martin A, Ballestín C, Garcia-Carbonero R, Castaño A, Lopez-Ríos F, López-Encuentra A, Sánchez-Cespedes M, Castellano D, Bartolomé A, Cortés-Funes H, Paz-Ares L. Prognostic value of KIT expression in small cell lung cancer. Lung Cancer 2007;56:405-13. [PMID: 17420067 DOI: 10.1016/j.lungcan.2007.01.029] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
38 Yuan T, Sun S, Cao Z, Feng X, Gao Y. Prognostic immunohistochemical markers for small cell lung cancer: A review. Pathol Res Pract 2021;217:153311. [PMID: 33310282 DOI: 10.1016/j.prp.2020.153311] [Reference Citation Analysis]
39 Mojica WD, Saxena R, Starostik P, Cheney RT. CD117+ small cell lung cancer lacks the asp 816-->val point mutation in exon 17. Histopathology 2005;47:517-22. [PMID: 16242000 DOI: 10.1111/j.1365-2559.2005.02259.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
40 Goldstein NS. C-kit expression in small cell lung carcinomas. Human Pathology 2003;34:827. [DOI: 10.1016/s0046-8177(03)00186-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Jha V, Sharma P, Mandal AK. Utility of Cluster of Differentiation 5 and Cluster of Differentiation 117 Immunoprofile in Distinguishing Thymic Carcinoma from Pulmonary Squamous Cell Carcinoma: A Study on 1800 Nonsmall Cell Lung Cancer Cases. Indian J Med Paediatr Oncol 2017;38:430-3. [PMID: 29333007 DOI: 10.4103/ijmpo.ijmpo_148_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
42 Pelosi G, Barisella M, Pasini F, Leon ME, Veronesi G, Spaggiari L, Fraggetta F, Iannucci A, Masullo M, Sonzogni A, Maffini F, Viale G. CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients. Mod Pathol 2004;17:711-21. [DOI: 10.1038/modpathol.3800110] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
43 Fukushima M, Homma K, Hashimoto T, Suzuki R, Koike T. Histologically unique case of combined small cell and squamous cell carcinoma in a polypoid bronchial tumor. Pathol Int 2005;55:785-91. [PMID: 16287494 DOI: 10.1111/j.1440-1827.2005.01907.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Pelosi G, Masullo M, Leon ME, Veronesi G, Spaggiari L, Pasini F, Sonzogni A, Iannucci A, Bresaola E, Viale G. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Virchows Arch 2004;445:449-55. [DOI: 10.1007/s00428-004-1106-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
45 Terada T. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes. Arch Gynecol Obstet 2010;282:413-6. [PMID: 20035340 DOI: 10.1007/s00404-009-1324-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
46 Lu SY, Huang CC, Hsiung CY, Eng HL, Huang HY. Primary lymphoepithelioma-like carcinoma of minor salivary gland: a case report with immunohistochemical and in situ hybridization studies. Head Neck 2006;28:182-6. [PMID: 16240326 DOI: 10.1002/hed.20312] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
47 Lapoint RJA, Bourne PA, Wang HL, Xu H. Coexpression of c-kit and bcl-2 in Small Cell Carcinoma and Large Cell Neuroendocrine Carcinoma of the Lung. Applied Immunohistochemistry & Molecular Morphology 2007;15:401-6. [DOI: 10.1097/01.pai.0000213153.41440.7d] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
48 Yasuda A, Sawai H, Takahashi H, Ochi N, Matsuo Y, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T. Stem Cell Factor/c-kit Receptor Signaling Enhances the Proliferation and Invasion of Colorectal Cancer Cells Through the PI3K/Akt Pathway. Dig Dis Sci 2007;52:2292-300. [DOI: 10.1007/s10620-007-9759-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
49 Akintola-Ogunremi O, Pfeifer JD, Tan BR, Yan Y, Zhu X, Hart J, Goldblum JR, Burgart L, Lauwers GY, Montgomery E. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas. Am J Surg Pathol. 2003;27:1551-1558. [PMID: 14657715 DOI: 10.1097/00000478-200312000-00008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
50 Diniz G, Aktas S, Ortac R, Tunakan M, Unlu I, Vergin C. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy. Pathology - Research and Practice 2006;202:671-7. [DOI: 10.1016/j.prp.2006.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Motegi A, Sakurai S, Nakayama H, Sano T, Oyama T, Nakajima T. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Pathol Int. 2005;55:106-112. [PMID: 15743318 DOI: 10.1111/j.1440-1827.2005.01806.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
52 Zigeuner R, Ratschek M, Langner C. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas. BJU Int 2005;95:315-8. [PMID: 15679785 DOI: 10.1111/j.1464-410X.2005.05290.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
53 Kang JS, Lee CJ, Lee JM, Rha JY, Song KW, Park MH. Follicular expression of c-Kit/SCF and inhibin-alpha in mouse ovary during development. J Histochem Cytochem 2003;51:1447-58. [PMID: 14566017 DOI: 10.1177/002215540305101105] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
54 Shafiee F, Aucoin MG, Jahanian-Najafabadi A. Targeted Diphtheria Toxin-Based Therapy: A Review Article. Front Microbiol 2019;10:2340. [PMID: 31681205 DOI: 10.3389/fmicb.2019.02340] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
55 Terada T. Small cell neuroendocrine carcinoma of the prostate: incidence and a report of four cases with an examination of KIT and PDGFRA. Prostate 2012;72:1150-6. [PMID: 22127977 DOI: 10.1002/pros.22464] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
56 Roden AC, Greipp PT, Knutson DL, Kloft-Nelson SM, Jenkins SM, Marks RS, Aubry MC, García JJ. Histopathologic and Cytogenetic Features of Pulmonary Adenoid Cystic Carcinoma. J Thorac Oncol 2015;10:1570-5. [PMID: 26309189 DOI: 10.1097/JTO.0000000000000656] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
57 Pozzobon M, Marafioti T, Hansmann ML, Natkunam Y, Mason DY. Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol 2004;124:519-33. [PMID: 14984504 DOI: 10.1111/j.1365-2141.2004.04802.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
58 Lin Y, Chang Y, Ho J, Lin H, Tsai Y, Chiang C, Wang W, Gao H. C-kit Expression of Melanocytic Neoplasm and Association With Clinicopathological Parameters and Anatomic Locations in Chinese People. The American Journal of Dermatopathology 2013;35:569-75. [DOI: 10.1097/dad.0b013e318279566a] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]
59 Vankova B, Behenska K, Bauer M, Sedivcova M, Daumova M, Agaimy A, Michal M, Daum O. Morphological features useful in the differential diagnosis between undifferentiated carcinoma and gastrointestinal stromal tumor. Ann Diagn Pathol 2020;46:151527. [PMID: 32388398 DOI: 10.1016/j.anndiagpath.2020.151527] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Hassan HT. c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications. Leuk Res 2009;33:5-10. [PMID: 18639336 DOI: 10.1016/j.leukres.2008.06.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
61 Potala S, Verma RS. A novel fusion protein diphtheria toxin-stem cell factor (DT-SCF)-purification and characterization. Appl Biochem Biotechnol 2010;162:1258-69. [PMID: 20084469 DOI: 10.1007/s12010-009-8896-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
62 Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205-220. [PMID: 16082245 DOI: 10.1097/01.pai.0000173054.83414.22] [Cited by in Crossref: 314] [Cited by in F6Publishing: 293] [Article Influence: 19.6] [Reference Citation Analysis]
63 Wang HL, Lu DW. Overexpression of c-kit protein is an infrequent event in small cell carcinomas of the uterine cervix. Mod Pathol 2004;17:732-8. [PMID: 15044919 DOI: 10.1038/modpathol.3800112] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
64 Szánthó E, Kárai B, Ivády G, Bedekovics J, Szegedi I, Petrás M, Ujj G, Ujfalusi A, Kiss C, Kappelmayer J, Hevessy Z. Comparative Analysis of Multicolor Flow Cytometry and Immunohistochemistry for the Detection of Disseminated Tumor Cells. Appl Immunohistochem Mol Morphol 2018;26:305-15. [PMID: 28426528 DOI: 10.1097/PAI.0000000000000519] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
65 Ustun C, DeRemer DL, Akin C. Tyrosine kinase inhibitors in the treatment of systemic mastocytosis. Leuk Res 2011;35:1143-52. [PMID: 21641642 DOI: 10.1016/j.leukres.2011.05.006] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 7.3] [Reference Citation Analysis]